ADVM Valuation

Adverum Biotechnologies Inc

Add to Watchlist

Advanced Chart

3.490

+0.160(+4.800%)

Overview
Forecast
Valuation

ADVM Relative Valuation

ADVM's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, ADVM is overvalued; if below, it's undervalued.

Historical Valuation

Adverum Biotechnologies Inc (ADVM) is now in the Fair zone, suggesting that its current forward PS ratio of 512.60 is considered Fairly compared with the five-year average of 762.22. The fair price of Adverum Biotechnologies Inc (ADVM) is between 0.39 to 6.23 according to relative valuation methord.

Relative Value

Fair Zone

0.39-6.23

Current Price：3.49

Fair

Trailing

Forward

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

1.03

P/B

Median3y

0.85

Median5y

1.32

-133.47

FCF Yield

Median3y

-97.97

Median5y

-72.68

Competitors Valuation Multiple

The average P/S ratio for ADVM's competitors is 170.07, providing a benchmark for relative valuation. Adverum Biotechnologies Inc Corp (ADVM) exhibits a P/S ratio of 512.60, which is 201.40% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

ADVM.O

Adverum Biotechnologies Inc

512.60

Average P/S: 170.07

72.91M